本文章的引用
本文章的通讯作者
本文章的类型
本文章的开放获取政策
本文章的Google引用次数
本文章的点击和下载次数
- 本文章浏览次数 (3165)
All Articles published online
|
2013-05-28 (publication date) through 2024-04-26
本文章的被引频次
本文章的期刊信息
出版物名称
世界华人消化杂志
ISSN
1009-3079
本文章的出版商
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | 高净, 江学良. 低剂量英夫利昔单抗不同给药次数治疗激素抵抗型溃疡性结肠炎. 世界华人消化杂志 2013; 21(15): 1453-1457 [DOI: 10.11569/wcjd.v21.i15.1453] |
|---|---|
| URL: | https://www.wjgnet.com/1009-3079/full/v21/i15/1453.htm |
| 编号 | Citing Articles |
| 1 |
Rachel Archer, Paul Tappenden, Shijie Ren, Marrissa Martyn-St James, Rebecca Harvey, Hasan Basarir, John Stevens, Christopher Carroll, Anna Cantrell, Alan Lobo, Sami Hoque. Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model. Health Technology Assessment 2016; 20(39): 1 doi: 10.3310/hta20390
|